Ask AI

Treatment Considerations for a Patient Case Example With Relapsed/Refractory Multiple Myeloma

Interact with our new AI patient case platform to talk about management of a patient with heavily pretreated relapsed/refractory multiple myeloma. This program will help you think through the use of CAR T-cell therapy and bispecific antibodies in R/R MM, including efficacy and safety insights and practical considerations for administration and adverse event monitoring.

Share

Program Content

Activities

ACTiconsult Relapsed Refractory Myeloma
 Treatment Considerations for a Patient Case Example With Relapsed/Refractory Multiple Myeloma
ACTiconsult
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2025

Expires: June 04, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education